In the evaluation of patients with suspected myopathy, molecular genetics has supplanted the need for electrodiagnostic (EDX) studies or muscle biopsy in many patients with inherited conditions. Moreover, in patients with suspected myopathy and no evidence of an inherited condition, a muscle biopsy ultimately will be required for definitive diagnosis, regardless of the findings on EDX studies. Despite these facts, EDX studies, especially the needle electromyography (EMG) examination, continue to play an important role in the evaluation of patients with suspected myopathy ( Fig. 38.1 ). EMG can often confirm the presence of a myopathy, as well as add diagnostic information if certain types of spontaneous activity are present. For example, fibrillation potentials and positive sharp waves in a myopathy suggest the possibility of inflammation or necrosis, whereas myotonic discharges suggest one of the myotonic muscle or periodic paralysis disorders (see Chapter 39 ), acid maltase deficiency, myotubular myopathy, myofibrillar myopathies, or certain toxic myopathies. Additionally, EMG may be helpful in suggesting alternate diagnoses that can mimic myopathy clinically.

Fig. 38.1
Role of electromyography (EMG) in the evaluation of myopathy.
HLTV , Human T-cell leukemia virus; NMJ , neuromuscular junction.

EMG can also be useful in directing the site for a muscle biopsy in a patient with a myopathy. The EMG examination has the advantage that multiple muscles and sites can be sampled easily and often can suggest a suitable muscle to biopsy. It is always desirable to biopsy an unequivocally abnormal muscle yet one that is not end stage. However, biopsy is always recommended on the side contralateral to the EMG examination (see later).

Although the EMG examination may yield valuable information in the evaluation of suspected myopathy, mild cases may be especially difficult to interpret. Some myopathies, including steroid myopathy, may have minimal or no changes on EMG. In addition, some disorders of the neuromuscular junction (NMJ) may present with very similar clinical and EDX findings. Close attention to clinical detail, and often further EDX studies, including repetitive nerve stimulation and single-fiber EMG, may be required to differentiate between a myopathy and NMJ disorder. In addition, neuromuscular ultrasound can add key information in selected cases of myopathy, and is discussed later in the chapter.

Clinical

Myopathies present as pure motor syndromes without any disturbance of sensory or autonomic function. In most myopathies, symptoms tend to be bilateral and affect proximal muscles preferentially. Patients usually complain of difficulty rising from chairs, going up and down stairs, or reaching with their arms. Although most myopathies are symmetric and proximal, there are exceptions to both. For example, inclusion body myositis (IBM) and facioscapulohumeral muscular dystrophy may be very asymmetric. Myotonic dystrophy, distal hereditary myopathies, and IBM may preferentially affect distal more than proximal muscles. In some myopathies, ocular and bulbar muscles may be affected. Deep tendon reflexes are generally preserved or, if reduced, are in proportion to the degree of muscle wasting and weakness.

In evaluating a patient with suspected myopathy, it is important to determine whether symptoms are exercise induced. Such symptoms may manifest as fatigability, exercise-induced muscle cramps, or swelling. Patients who present with exercise-induced muscle cramps (see later) may develop frank weakness, swelling, and, if severe enough, myoglobulinuria. These latter symptoms suggest an inherited disorder of muscle energy metabolism. Note that although fatigability is certainly common in myopathies, frank muscle weakness that develops with exercise over a short period of time, if not accompanied by cramps, suggests a disorder of the NMJ rather than a myopathy. Additionally, patients with Lambert-Eaton myasthenic syndrome (LEMS) and some rare patients with myasthenia gravis (MG) present with isolated proximal muscle weakness mimicking a myopathy. In addition, adult onset spinal muscular atrophy, including X-linked bulbospinal muscular atrophy, usually presents with proximal muscle weakness and mimics the typical pattern of a myopathy.

Disorders of muscle can be simplified into the following categories: (1) muscular dystrophies, (2) inflammatory myopathies, (3) necrotizing autoimmune myopathies (NAMs), (4) endocrine associated myopathies, (4) drug-induced and toxic myopathies, (6) metabolic myopathies, (7) congenital myopathies, and (8) myopathy associated with periodic paralysis.

Muscular dystrophies are inherited muscle disorders characterized by a progressive course and often an early onset, usually with a specific clinical and muscle biopsy pattern. In recent years, the genetic abnormality or specific gene product (e.g., dystrophin in Duchenne and Becker muscular dystrophy) has been discovered in several of these disorders. The more common muscular dystrophies include myotonic dystrophy, Duchenne muscular dystrophy, Becker muscular dystrophy, Emery-Dreifuss muscular dystrophy, facioscapulohumeral muscular dystrophy, oculopharyngeal muscular dystrophy, and the limb girdle muscular dystrophies.

Inflammatory myopathies are associated most commonly with a presumed immunologic attack and include polymyositis (PM), dermatomyositis (DM), and IBM. Other types of inflammatory myopathy include those caused by muscle infection by parasites, viruses, or bacteria. More recently, myositis has been in seen as a rare complication in cancer patients treated with the immune checkpoint inhibitors (ICPIs). These are monoclonal antibodies that target cytoplasmic T-lymphocyte associated antigen-4 (CTLA-4), programmed cell death receptor-1 (PD-1), or programmed cell death ligand-1 (PD-L1). These agents inhibit normal physiologic mechanisms that protect against autoimmunity. Although they are highly effective as immunotherapy in several types of refractory cancers, they can result in a large number of immune-related adverse effects (irAEs), including several neuromuscular conditions, including myositis. In our experience, myositis provoked by ICPIs is often associated with MG, is very severe, and can be very difficult to control.

NAMs are rare but increasingly recognized as an etiology of muscle weakness. Patients appear clinically similar to the common inflammatory myopathies with proximal weakness and elevated creatine kinase (CK) levels. However, on muscle biopsy, there are many necrotic fibers with little or no inflammation. Risk factors include statin use wherein patients develop an autoimmune response to statins, malignancy, and connective tissue diseases. Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) antibodies or anti–signal recognition particle (anti-SRP) antibodies may be present. On EDX, these myopathies have very similar findings to the inflammatory myopathies. However, although autoimmune, they are often much more difficult to treat.

Endocrine myopathies are often seen in disorders of the thyroid and adrenal glands. In addition, myopathy can accompany some cases of acromegaly and parathyroid disease.

Drug-induced and toxic myopathies are becoming increasingly common. Examples of common drug-induced and toxic myopathies include those caused by steroids, alcohol, colchicine, azidothymidine, clofibrate, and as a direct toxic effect of many of the cholesterol-lowering agents.

Metabolic myopathies are disorders of muscle resulting from inherited enzyme deficiencies important in intracellular energy production. They may present in one of three ways: (1) as cramps and myoglobinuria, (2) as part of a more diffuse neurologic syndrome, often involving the central nervous system, or (3) as a typical clinical proximal myopathy. In patients with cramps and myoglobinuria, the genetic defect often is found either in the glycogen or lipid metabolism pathways. These patients may be completely normal at rest but become symptomatic during or after exercise. In patients with disorders along the lipid pathway, symptoms commonly occur after an episode of long or forced exercise (e.g., a long march or mountain climbing). In patients with disorders along the glycogen pathway, symptoms commonly occur after brief, intense isometric exercise. Muscle aches and fatigue may begin during the exercise, followed by frank myoglobinuria. Headache, nausea, and vomiting may occur. Muscles become painful and swollen. The CK level often is dramatically elevated into the thousands. The most common of these are caused by a deficiency of carnitine palmitoyltransferase (CPT) along the lipid pathway and myophosphorylase (McArdle’s disease) along the glycogen pathway. Patients with defects in mitochondrial metabolism often present with a myopathy, as well as abnormalities involving other systems, including the central nervous system. Short stature, hearing loss, seizures, cardiac abnormalities, learning disabilities, and stroke-like episodes are common. Lastly, some rare defects in metabolism (i.e., carnitine or acid maltase deficiency) may present as a typical clinical slowly progressive myopathy with proximal weakness.

Congenital myopathies are a group of myopathies in which each disorder has a fairly specific muscle biopsy finding on histochemical staining (e.g., nemaline rods, central cores, fiber type disproportion, and myotubular myopathy). Typically, hematoxylin and eosin paraffin staining is normal or nonspecific. Although most patients present in the first few years of life, an occasional patient with a congenital myopathy presents in adulthood with one of these disorders. The clinical syndromes are nonspecific and tend to be slowly progressive or static. Genetic testing or muscle biopsy usually is needed for definitive diagnosis, unless there is a known confirmed diagnosis in the family.

Myopathy associated with periodic paralysis occurs in the setting of hypokalemic and hyperkalemic periodic paralysis (see Chapter 39 ). Patients develop proximal weakness in the fifth or sixth decade. Even those patients with hypokalemic periodic paralysis who have never experienced episodic weakness, a common scenario in affected females, invariably will develop a proximal vacuolar myopathy in adulthood.

Electrophysiologic Evaluation

Nerve Conduction Studies

Routine nerve conduction studies should always be done in patients with suspected myopathy ( Box 38.1 ). Sensory nerve conduction studies are always normal, unless there is a coexistent neuropathy. Because most myopathies preferentially affect proximal muscles and routine motor nerve conduction studies record distal muscles, motor nerve conduction studies are also usually normal. If the myopathy is severe enough to affect distal and proximal muscles or is one of the rare myopathies that preferentially affects distal muscles, motor studies may show decreased compound muscle action potential (CMAP) amplitudes with normal latencies and conduction velocities.

Box 38.1
Recommended Nerve Conduction Study Protocol for Myopathy

Routine studies:

  • 1.

    At least one motor and one sensory conduction study and corresponding F responses from the upper extremity (e.g., median motor and sensory, median F responses)

  • 2.

    At least one motor and one sensory conduction study and corresponding F responses from the lower extremity (e.g., tibial motor and sural sensory, tibial F responses)

Special considerations:

  • If the compound muscle action potential (CMAP) amplitudes are decreased or borderline, exercise the muscle maximally for 10 seconds, then repeat a single supramaximal distal stimulation, looking for a significant CMAP increment (>100% of baseline), suggestive of the diagnosis of Lambert-Eaton myasthenic syndrome.

  • If there is a clinical history of fatigability, fluctuating weakness, or any oculobulbar symptoms, repetitive nerve stimulation (3 Hz) of one distal muscle (e.g., ulnar nerve recording abductor digiti minimi) and one proximal muscle (e.g., the spinal accessory nerve recording the upper trapezius) should be performed. If a significant decrement is found with 3-Hz repetitive nerve stimulation of any muscle, then proceed with further testing, looking for a disorder of the neuromuscular junction (see Chapter 37 , Box 37.2 ). a

    a One can make a reasonably strong case to consider performing repetitive nerve stimulation (RNS) on all suspected myopathies. Rarely, neuromuscular junction disorders will present with proximal weakness, normal nerve conduction studies, and “myopathic” motor unit action potentials on needle electromyography. Without RNS, the diagnosis may be missed.

The major reason nerve conduction studies must be performed is to exclude other motor disorders that may mimic myopathy ( Box 38.2 ). Other than myopathy, pure motor disorders include motor neuron disease, rare cases of demyelinating polyneuropathy, and NMJ disorders. The nerve conduction studies in motor neuron disease and myopathies that affect distal muscles may be very similar. Differentiation is made based on the associated clinical features and needle EMG findings. Nerve conduction studies can easily differentiate demyelinating polyneuropathy from myopathy by the presence of conduction block or temporal dispersion, marked slowing of distal latencies and conduction velocity, or a combination of these findings.

Box 38.2
Disorders That May Mimic Myopathy

  • Motor neuron disease

    • Especially late-onset spinal muscular atrophy

    • X-linked bulbospinal muscular atrophy (Kennedy’s disease)

    • Some cases of the progressive muscular atrophy variant of amyotrophic lateral sclerosis

  • Neuromuscular junction disorders

    • Especially Lambert-Eaton myasthenic syndrome

    • Rare cases of restricted limb girdle myasthenia gravis

    • Rare cases of congenital myasthenic syndromes

  • Motor neuropathies

    • Usually demyelinating peripheral neuropathy (motor variants of chronic inflammatory demyelinating polyneuropathy; multifocal motor neuropathy with conduction block)

    • Rare cases of porphyric neuropathy preferentially affect proximal motor fibers

    • Diabetic amyotrophy (often affects proximal motor fibers, but usually with prominent pain)

  • Central nervous system lesions

    • Bilateral middle cerebral artery–anterior cerebral artery watershed strokes

Disorders of the NMJ present more of a challenge. Some NMJ disorders may present with proximal muscle weakness similar to myopathies. Postsynaptic disorders (e.g., MG) typically have normal CMAP amplitudes at rest. To demonstrate the NMJ abnormality, slow (3 Hz), repetitive nerve stimulation is required to demonstrate a decrement (see Chapter 37 ). Presynaptic disorders (e.g., LEMS) have a more characteristic nerve conduction pattern: CMAP amplitudes are low at rest with normal latencies and conduction velocities. Brief exercise (10 seconds) characteristically results in a marked increment of CMAP amplitude (typically >100% of baseline).

Electromyographic Approach

For the patient with suspected myopathy, the needle EMG examination must be individualized based on the distribution of the patient’s symptoms ( Box 38.3 ). Overall, examining distal and proximal muscles in both the upper and lower extremities is indicated. Sampling the paraspinal muscles (the most proximal muscles) often is very useful. As most myopathies affect proximal muscles, the yield of finding abnormalities increases as progressively more proximal muscles are sampled. In adult-onset acid maltase deficiency myopathy, for instance, prominent changes may be seen only in the most proximal muscles (paraspinals, diaphragm, and tensor fascia latae).

Box 38.3
Recommended Electromyographic Approach to Myopathy

Routine studies:

  • 1.

    At least two distal and two proximal muscles in the lower extremity (e.g., tibialis anterior, gastrocnemius, vastus lateralis, iliacus)

  • 2.

    At least two distal and two proximal muscles in the upper extremity (e.g., first dorsal interosseous, extensor indicis proprius, biceps brachii, medial deltoid)

  • 3.

    At least one paraspinal muscle

Special considerations:

  • Always try to study weak muscles. The number and distribution of muscles studied depend on the pattern of weakness.

  • In patients with clinical weakness of the long finger flexors, study the flexor digitorum profundus (FDP), especially if other limb muscles are long and large and appear “neuropathic.” Small and short MUAPs in the FDP should alert the electromyographer to the possible diagnosis of inclusion body myositis.

  • Try to study muscles that can easily be biopsied on the contralateral side (deltoid, biceps, vastus lateralis, gastrocnemius).

  • If the motor unit action potential (MUAP) parameters are indeterminate, consider the following:

    • Quantitative MUAP analysis: Accumulate 20 MUAPs from different locations within each muscle. Calculate the mean amplitude and duration and compare with age-matched controls for the muscle sampled.

    • Single-fiber electromyography: If MUAP parameters, recruitment, and activation pattern are normal when examined in weak muscles, then a neuromuscular junction disorder should be considered. Repetitive nerve stimulation should be performed first; if normal, single-fiber electromyography should be considered.

There are several other issues to keep in mind when performing EMG studies in suspected myopathies. First, motor unit action potentials (MUAPs) are typically small, short, and polyphasic. However, it is important to remember that not all small, short, and polyphasic MUAPs are “myopathic.” A similar pattern can occur in weak muscles with NMJ disorders, as well as with early reinnervation after severe denervation (i.e., nascent motor units [see Chapter 15 ]). Second, some myopathies may display minimal, equivocal, or no changes of MUAPs. This is most commonly seen in steroid myopathy and some metabolic and mitochondrial myopathies. Third, measuring the serum CK immediately after the EMG examination probably is not wise. The CK level may rise slightly as a consequence of the EMG examination (typically 1.5× normal). The last issue is that of which muscle to biopsy, because patients with suspected myopathy often go on to muscle biopsy. The EMG can be very helpful in identifying an appropriate muscle to biopsy. One should biopsy a muscle that is abnormal but not at end stage. It usually is advisable to biopsy a muscle contralateral to the side sampled by the EMG needle. Because the EMG needle may induce transient inflammatory changes on the muscle biopsy, it is best not to biopsy muscles that have been sampled by the EMG needle. One would not like to diagnose an inflammatory myopathy and inappropriately place a patient on high-dose steroids and immunosuppressants based on spurious inflammation on a biopsy caused by the EMG needle.

Spontaneous Activity in Myopathies

Fibrillation potentials and positive sharp waves usually are associated with neuropathic disorders (i.e., neuropathy, radiculopathy, motor neuron disease). However, denervating potentials occur frequently in many myopathic disorders . They are thought to most likely occur as a consequence of segmental inflammation or necrosis of muscle fibers, separating a distal, healthy portion of the muscle fiber from the part attached to the endplate ( Fig. 38.2 ). Infarction of small intramuscular nerve twigs by surrounding interstitial inflammation also is speculated to be a possible cause of denervation in inflammatory myopathies. Although the presence of denervating potentials in a patient with myopathy often suggests the diagnosis of an inflammatory myopathy, denervating potentials can occur in a variety of myopathies ( Box 38.4 ), including some toxic myopathies, several muscular dystrophies, and other inherited myopathies. In chronic myopathies, complex repetitive discharges may also be seen.

Fig. 38.2, Generation of fibrillation potentials in inflammatory myopathies.

Box 38.4
Myopathies With Denervating Features

  • Inflammatory myopathies

    • Polymyositis

    • Dermatomyositis

    • Inclusion body myositis

    • Human immunodeficiency virus-associated myopathy/polymyositis

    • Human T-cell lymphotropic virus-1 myopathy

    • Sarcoid myopathy

  • Dystrophies and other inherited myopathies

    • Dystrophin deficiency (Duchenne and Becker)

    • Facioscapulohumeral muscular dystrophy

    • Autosomal recessive distal muscular dystrophy

    • Emery-Dreifuss muscular dystrophy

    • Oculopharyngeal muscular dystrophy

    • Limb-Girdle muscular dystrophy-2A

    • Myofibrillar myopathies

  • Congenital myopathies

    • Centronuclear/myotubular myopathy

    • Nemaline rod myopathy

  • Metabolic myopathies

    • Acid maltase deficiency myopathy

    • Carnitine deficiency myopathy

    • Debrancher deficiency myopathy

  • Toxic myopathies

    • Colchicine, azidothymidine, alcohol, chloroquine, hydroxychloroquine, pentazocine, clofibrate, ε-aminocaproic acid, cholesterol-lowering agents, critical illness myopathy

  • Necrotizing autoimmune myopathy (non-inflammatory, immune-mediated)

  • Amyloid myopathy

  • Infectious myopathies

    • Trichinosis

    • Toxoplasmosis

    • Pyomyositis

The presence of myotonic discharges yields additional information. A myotonic discharge is the spontaneous firing of a muscle fiber that waxes and wanes in both amplitude and frequency. The morphology of a myotonic discharge is either a positive wave or a brief spike potential. This morphology is the same as that of acute denervating potentials (i.e., fibrillation potentials and positive sharp waves). This should not be surprising because myotonic discharges are generated by muscle fibers as well. Myotonic discharges can be differentiated from fibrillation potentials and positive sharp waves by the waxing and waning of both firing frequency and amplitude. Remember that fibrillation potentials and positive sharp waves, in contrast, fire at a very regular rate. Myotonic discharges may be seen in myotonic dystrophy (types 1 and 2), myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. They can also be seen in other myopathies, including acid maltase deficiency (especially in the paraspinal muscles), myotubular (centronuclear) myopathy, some drug-induced myopathies (e.g., chloroquine, colchicine, cholesterol-lowering agents), and, occasionally, in PM.

The last type of “spontaneous activity” to recognize is a contracture , which is the complete absence of any EMG activity in a muscle while it is in the contracted state. Superficially, a muscle cramp and a contracture may appear similar clinically—the painful involuntary contraction of a muscle. However, during muscle cramps, which are neuropathic in origin, the EMG shows involuntary firing of MUAPs at a high frequency, whereas during a contracture, there is electrical silence. Contractures are seen only in rare metabolic myopathies (e.g., McArdle’s disease, CPT deficiency) and occur as a result of insufficient energy available to break the actin-myosin bonds and return the muscle to a relaxed state. The “cramps” experienced by patients with metabolic myopathies such as McArdle’s disease or CPT deficiency are, in fact, contractures.

Motor Unit Action Potential Analysis in Myopathies

Differentiating between myopathic and neuropathic disorders usually is primarily based on analysis of MUAP parameters ( Fig. 38.3 ). In most myopathies, there is dropout or dysfunction of individual muscle fibers that effectively decreases the size of the motor unit ( Fig. 38.4 ). In this situation, the actual number of motor units (i.e., anterior horn cells and axons) does not change. Only in the rare case of a very severe myopathy where every muscle fiber in a motor unit drops out does the effective number of motor units decrease.

Fig. 38.3, Myopathic motor unit action potentials (MUAPs).

Fig. 38.4, Motor unit territory in myopathy.

Remember that there is a large normal variation in MUAP parameters. In borderline cases, it is advisable to measure at least 20 MUAPs and compare them with age-matched controls for the muscle sampled. Analysis of MUAPs, either subjectively or, more ideally, quantitatively, commonly allows a diagnosis of myopathy by noting specific changes in MUAP duration, amplitude, phases, and recruitment pattern.

MUAP duration is the most important parameter to measure in myopathy. Duration most closely reflects the total number of muscle fibers in a motor unit, including those muscle fibers at a distance from the recording electrode. The measurement of duration usually does not include linked potentials. In myopathy, duration characteristically decreases. The reduction in duration is best explained by the random dropout of muscle fibers ( Fig. 38.5 ). Of course, the finding of one brief MUAP does not make the electrodiagnosis of myopathy. Because there is a normal range of MUAP duration that varies depending on age and the muscle studied, one must sample several MUAPs to determine the mean duration. In myopathy, although the mean duration decreases, some of the MUAPs may be normal or possibly of long duration ( Fig. 38.6 ). In mild or equivocal cases, quantitative EMG of 10–20 MUAPs should be performed. In addition, it is important to remember that brief-duration MUAPs may be seen in conditions other than myopathy. Any disorder that effectively causes loss or dysfunction of individual muscle fibers (e.g., myopathy, NMJ disorders with block, disorders of the terminal axon) without affecting the motor neuron and its main axon can result in short-duration MUAPs ( Box 38.5 ). A similar situation occurs in early reinnervation after severe denervation, when only a few fibers have successfully reinnervated, resulting in nascent (early reinnervated) motor unit potentials, which are also short and small. This point again emphasizes that the entire EMG examination must be taken as a whole and interpreted in light of the nerve conduction studies, as well as the history and examination, before a diagnosis is reached.

Fig. 38.5, Model of a myopathic motor unit action potential (MUAP).

Fig. 38.6, Motor unit action potential (MUAP) durations in myopathy.

Box 38.5
Conditions Associated With Small, Short, Polyphasic Motor Unit Action Potentials

  • Myopathy

  • Neuromuscular junction disorders (myasthenia gravis, Lambert-Eaton myasthenic syndrome)

  • Early reinnervation after severe denervation (i.e., nascent motor unit potentials)

  • Periodic paralysis (during attack)

  • Disorders that selectively affect terminal axons (? paraneoplastic)

Somewhat surprisingly, chronic myopathies may have very long MUAP durations or frequently have linked or satellite potentials. These findings likely are secondary to fiber splitting or collateral sprouting from reinnervation in those myopathies associated with necrosis and subsequent denervation. In the chronic or late stage of a myopathy, it may be very difficult to distinguish a myopathic from a neuropathic disorder based on the duration of the MUAPs alone.

MUAP amplitude depends on just the few muscle fibers that are very close to the needle electrode. In myopathy, the amplitude commonly is decreased, but it can also be normal or increased if the needle electrode is placed near split or reinnervated fibers.

MUAP phases often are increased (more than four phases) in myopathy, but this is a nonspecific finding. The number of phases is primarily a measure of synchrony, and polyphasia may be seen in both myopathic and neuropathic disorders. Presumably, many of the remaining muscle fibers are dysfunctional and do not fire as synchronously as normal.

One of the most important findings in a myopathy is the presence of an early recruitment pattern. In myopathies in which there is dropout of individual muscle fibers from a motor unit, the motor unit becomes smaller and subsequently can generate less force. Early recruitment refers to the inappropriate firing of many MUAPs to generate a small amount of force. In general, only the electromyographer performing the study can assess early recruitment. Assessing early recruitment requires knowledge of how much force is being generated for the number of MUAPs that are firing. In myopathy, the number of MUAPs firing (recruitment) is appropriate for the firing frequency (activation); what is inappropriate is the number of MUAPs firing for the degree of force generated.

Only very rarely is the recruitment of MUAPs actually reduced in myopathy. This occurs only in the setting of end-stage muscle disease if all the muscle fibers of a single motor unit are lost, thereby causing an actual reduction in the number of motor units. This results in a reduced recruitment pattern on EMG. This situation is extremely uncommon but may arise in some very chronic myopathies that involve certain muscles severely, such as the quadriceps in IBM.

Single-Fiber Electromyography in Myopathy

Single-fiber EMG (see Chapter 37 ) in patients with myopathy is commonly associated with increased jitter and blocking, especially in those myopathies associated with abnormal spontaneous activity. This finding emphasizes that increased jitter and blocking, although very sensitive to disorders of the NMJ, are not specific to these disorders. Any neuropathic or myopathic condition that involves any degree of denervation and reinnervation results in newly formed or dying NMJs, which in turn lead to abnormalities on single-fiber EMG. In differentiating a myopathy from a disorder of NMJ transmission, single-fiber EMG is most helpful in those cases where both nerve conduction and routine needle EMG findings are normal. In this setting, if the single-fiber EMG is abnormal, a disorder of NMJ transmission is more likely than a primary muscle disorder.

Clinical and Electrophysiologic Patterns in Selected Myopathies

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here